BubR1 is involved in regulation of DNA damage responses

Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised resp...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 25; no. 25; pp. 3598 - 3605
Main Authors FANG, Y, LIU, T, WANG, X, YANG, Y.-M, DENG, H, KUNICKI, J, TRAGANOS, F, DARZYNKIEWICZ, Z, LU, L, DAI, W
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing 15.06.2006
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1(+/-) murine fibroblast cells (MEF) were defective in undergoing G(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1(+/+) MEF cells remained arrested in mitosis, BubR1(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk.
AbstractList Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo- insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1 super(+/-) murine fibroblast cells (MEF) were defective in undergoing G sub(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1 super(+/+) MEF cells remained arrested in mitosis, BubR1 super(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1 super(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1 super(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk.
Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1 super(+/-) murine fibroblast cells (MEF) were defective in undergoing G sub(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1 super(+/+) MEF cells remained arrested in mitosis, BubR1 super(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1 super(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1 super(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk.Oncogene (2006) 25, 3598-3605. doi:10.1038/sj.onc.1209392; published online 30 January 2006
Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1(+/-) murine fibroblast cells (MEF) were defective in undergoing G(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1(+/+) MEF cells remained arrested in mitosis, BubR1(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk.
Defective mitotic spindles or an impaired spindle–kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1+/− murine fibroblast cells (MEF) were defective in undergoing G2/M arrest. Thus, whereas in the presence of DNA damage BubR1+/+ MEF cells remained arrested in mitosis, BubR1+/− MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1+/− MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1+/− MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk.
Audience Academic
Author DARZYNKIEWICZ, Z
LIU, T
WANG, X
YANG, Y.-M
DENG, H
DAI, W
LU, L
FANG, Y
KUNICKI, J
TRAGANOS, F
Author_xml – sequence: 1
  givenname: Y
  surname: FANG
  fullname: FANG, Y
  organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States
– sequence: 2
  givenname: T
  surname: LIU
  fullname: LIU, T
  organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States
– sequence: 3
  givenname: X
  surname: WANG
  fullname: WANG, X
  organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States
– sequence: 4
  givenname: Y.-M
  surname: YANG
  fullname: YANG, Y.-M
  organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States
– sequence: 5
  givenname: H
  surname: DENG
  fullname: DENG, H
  organization: Proteomics Core Facility, Rockefeller University, New York, NY 10021, United States
– sequence: 6
  givenname: J
  surname: KUNICKI
  fullname: KUNICKI, J
  organization: Department of Medicine, New York Medical College, Valhalla, NY 10595, United States
– sequence: 7
  givenname: F
  surname: TRAGANOS
  fullname: TRAGANOS, F
  organization: Department of Medicine, New York Medical College, Valhalla, NY 10595, United States
– sequence: 8
  givenname: Z
  surname: DARZYNKIEWICZ
  fullname: DARZYNKIEWICZ, Z
  organization: Grander Cancer Institute, New York Medical College, Valhalla, NY 10595, United States
– sequence: 9
  givenname: L
  surname: LU
  fullname: LU, L
  organization: Division of Molecular Medicine, Harbor-UCLA Medical Center, University of California Los Angeles, Torrance, CA 90502, United States
– sequence: 10
  givenname: W
  surname: DAI
  fullname: DAI, W
  organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17863475$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16449973$$D View this record in MEDLINE/PubMed
BookMark eNqFkd1rFDEUxYO02G311TdlqLRvs-Y7k8e1VlsoCqLPIZO5WWaZSdZkpuB_b5YOLEhF7kMuN79zT8I5RychBkDoDcFrglnzIe_WMbg1oVgzTV-gFeFK1kJofoJWWAtca8roGTrPeYcxVhrTl-iMSM61VmyF1Me5_U6qPld9eIzDI3SlqRJs58FOfQxV9NWnr5uqs6PdQrnI-xgy5Ffo1Nshw-vlvEA_P9_-uLmrH759ub_ZPNROSD3VnSQWN56D81ZYxqVotZNtq7SwjQfFLeGuzAlh3rWSUw-aAEiJi671DbtA10979yn-miFPZuyzg2GwAeKcDSWMYaLk_0GsWCOoKOD7v8BdnFMonzBUcsIKQ3GhLv9JUcVEgxtyXLW1A5g--Dgl6w6-ZkMajYWk8mC4foYq1cHYuxKn78v8OYFLMecE3uxTP9r02xBsDqmbvDMldbOkXgTvlsfO7QjdEV9iLsDVAtjs7OCTDa7PR041knF1cH77xAU7zQmOwGL0B6-NvJs
CODEN ONCNES
CitedBy_id crossref_primary_10_1016_j_tig_2019_01_003
crossref_primary_10_1016_j_virol_2010_02_003
crossref_primary_10_1074_jbc_M608406200
crossref_primary_10_1007_s12032_013_0526_7
crossref_primary_10_1016_j_devcel_2016_10_023
crossref_primary_10_1016_j_molmed_2015_04_003
crossref_primary_10_1016_j_molcel_2015_03_034
crossref_primary_10_4161_cc_28419
crossref_primary_10_1038_ncb2643
crossref_primary_10_1016_j_ceb_2006_10_002
crossref_primary_10_1534_g3_117_1122
crossref_primary_10_1016_j_febslet_2006_03_081
crossref_primary_10_1158_1541_7786_MCR_06_0395
crossref_primary_10_1038_nrc2781
crossref_primary_10_1586_epr_11_63
crossref_primary_10_1136_jcp_2006_044305
crossref_primary_10_1534_g3_111_000265
crossref_primary_10_1093_hmg_ddaa076
crossref_primary_10_1016_j_clon_2008_06_010
crossref_primary_10_1002_ijc_31718
crossref_primary_10_1016_j_febslet_2011_05_013
crossref_primary_10_1016_j_chemosphere_2020_128994
crossref_primary_10_1186_s13008_015_0009_7
crossref_primary_10_1158_0008_5472_CAN_07_2266
crossref_primary_10_1002_hed_21342
crossref_primary_10_1155_2012_195903
crossref_primary_10_1128_JVI_01515_08
crossref_primary_10_1016_j_biocel_2009_11_011
crossref_primary_10_1038_s41388_021_02021_y
crossref_primary_10_18632_oncotarget_6432
crossref_primary_10_1016_j_ccr_2006_12_003
crossref_primary_10_1038_nrm1963
crossref_primary_10_1038_onc_2010_53
crossref_primary_10_1016_j_bbamcr_2008_08_006
crossref_primary_10_1016_j_tcb_2008_03_003
crossref_primary_10_1128_MCB_00310_06
crossref_primary_10_3389_fcell_2021_700162
crossref_primary_10_1021_acs_jmedchem_3c00963
crossref_primary_10_1038_bjc_2013_189
crossref_primary_10_1016_j_bbcan_2008_04_001
crossref_primary_10_1016_j_redox_2023_102701
crossref_primary_10_1371_journal_pgen_1000015
crossref_primary_10_4161_cc_24403
crossref_primary_10_1371_journal_pgen_1005150
crossref_primary_10_1016_j_bbrc_2007_04_125
crossref_primary_10_1016_j_dnarep_2011_10_018
crossref_primary_10_1016_j_yexcr_2019_01_013
crossref_primary_10_1016_j_semcdb_2013_02_001
crossref_primary_10_1002_mc_20412
crossref_primary_10_1186_1747_1028_5_13
crossref_primary_10_1016_j_molcel_2015_11_006
Cites_doi 10.1074/jbc.M211641200
10.1038/sj.onc.1207374
10.1016/S0959-437X(02)00282-4
10.1038/35023629
10.1093/emboj/cdg206
10.1038/32688
10.1038/ng997
10.1038/nature03061
10.1191/0267659103pf684oa
10.1146/annurev.biochem.73.011303.073723
10.1038/sj.onc.1207411
10.1074/jbc.M203793200
10.1038/sj.onc.1208218
10.1073/pnas.0407822102
10.1016/S0092-8674(03)00755-4
10.1038/35044005
10.1038/nature02330
10.1074/jbc.272.45.28646
10.1038/25292
10.1038/sj.onc.1207873
10.1074/jbc.M007269200
10.1038/ng1449
10.1126/science.1084468
10.1128/MCB.22.10.3450-3459.2002
10.1146/annurev.genet.37.042203.120656
10.1074/jbc.M200620200
10.1016/j.dnarep.2004.06.002
10.1158/0008-5472.CAN-03-3119
10.1016/j.cell.2004.12.002
10.1016/S0960-9822(02)01226-5
ContentType Journal Article
Copyright 2006 INIST-CNRS
COPYRIGHT 2006 Nature Publishing Group
Copyright Nature Publishing Group Jun 15, 2006
Nature Publishing Group 2006.
Copyright_xml – notice: 2006 INIST-CNRS
– notice: COPYRIGHT 2006 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jun 15, 2006
– notice: Nature Publishing Group 2006.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PQEST
PQQKQ
PQUKI
PRINS
Q9U
RC3
DOI 10.1038/sj.onc.1209392
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (Proquest)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest research library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList Genetics Abstracts
Genetics Abstracts
Research Library Prep
Research Library Prep
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
EISSN 1476-5594
EndPage 3605
ExternalDocumentID 1060736401
A189056265
10_1038_sj_onc_1209392
16449973
17863475
1209392
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA028704-27
– fundername: NCI NIH HHS
  grantid: R01 CA028704
– fundername: NCI NIH HHS
  grantid: R01-CA90658
GroupedDBID -
-Q-
0R
123
29N
2WC
39C
3O-
3V.
4.4
53G
55
5RE
7X7
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AADWK
AAPBV
AAWBL
AAYJO
AAZLF
ABAWZ
ABDBF
ABDEU
ABFLS
ABGIJ
ABPTK
ABUWG
ACGFS
ACKTT
ACPRK
ADBBV
ADBIT
ADHDB
ADQMX
AEDAW
AEJRE
AENEX
AEXYK
AFKRA
AFSHS
AGEZK
AHMBA
AHSBF
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBAFP
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
COF
CS3
DIK
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EPL
ESX
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRP
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HVGLF
HZ
IAO
IHR
INH
INR
ITC
JSO
KQ8
L7B
LK8
M0L
M1P
M2O
M7P
N9A
NAO
O9-
OK1
OVD
P2P
PADUT
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q-
Q2X
RIG
RNS
RNT
RNTTT
SNX
SNYQT
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UDS
W2D
WH7
X7M
ZA5
---
.55
.GJ
08R
0R~
36B
406
70F
AANZL
AATNV
AAUGY
AAYFA
ABEFU
ABLJU
ACBMV
ACBRV
ACBYP
ACGFO
ACIGE
ACMJI
ACRQY
ACTTH
ACVWB
ADFRT
ADMDM
ADYYL
AEFTE
AEVLU
AFFNX
AFNRJ
AGGBP
AGHAI
AILAN
AJCLW
AJDOV
AMRJV
AMYLF
BAWUL
CCPQU
DNIVK
DPUIP
EMOBN
HZ~
IQODW
IWAJR
JZLTJ
NQJWS
NXXTH
NYICJ
SOHCF
SRMVM
UKHRP
ZXP
~8M
AAYZH
ABAKF
ABJNI
ABZZP
ACAOD
ACZOJ
AEMSY
AFBBN
AGQEE
ALIPV
CGR
CUY
CVF
ECM
EIF
HMCUK
NPM
AAYXX
CITATION
AHPSJ
FIGPU
7TM
7TO
7U9
7XB
8FD
8FK
FR3
H94
K9.
MBDVC
P64
Q9U
RC3
ID FETCH-LOGICAL-c569t-d61a08f4ecfa5a3465b9c6bb795a8fe74a14ca34113fcb642fe91ee6601a0bf83
IEDL.DBID BENPR
ISSN 0950-9232
IngestDate Sat Oct 26 01:38:02 EDT 2024
Fri Oct 25 11:49:09 EDT 2024
Wed Nov 06 07:46:47 EST 2024
Thu Oct 10 19:36:21 EDT 2024
Fri Feb 23 00:21:48 EST 2024
Tue Nov 12 23:43:40 EST 2024
Fri Sep 27 02:37:03 EDT 2024
Tue Oct 15 23:30:47 EDT 2024
Sun Oct 22 16:03:39 EDT 2023
Thu Oct 07 19:41:30 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 25
Keywords Regulation(control)
TP53 Gene
BuhR1: DNA damage: checkpoint: p53
DNA
Cell cycle
CDKN1A Gene
PARP
Lesion
Carcinogenesis
Control point
p21
Tumor suppressor gene
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c569t-d61a08f4ecfa5a3465b9c6bb795a8fe74a14ca34113fcb642fe91ee6601a0bf83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1038/sj.onc.1209392
PMID 16449973
PQID 227358081
PQPubID 36330
PageCount 8
ParticipantIDs proquest_miscellaneous_21330176
proquest_miscellaneous_20738525
proquest_journals_2641352520
proquest_journals_227358081
gale_infotracmisc_A189056265
gale_infotracacademiconefile_A189056265
crossref_primary_10_1038_sj_onc_1209392
pubmed_primary_16449973
pascalfrancis_primary_17863475
nature_primary_1209392
ProviderPackageCode ABDEU
AEDAW
AAZLF
-Q-
AADWK
AAYJO
ADQMX
EE.
RNTTT
SWTZT
ABGIJ
RNT
NAO
PublicationCentury 2000
PublicationDate 2006-06-15
PublicationDateYYYYMMDD 2006-06-15
PublicationDate_xml – month: 06
  year: 2006
  text: 2006-06-15
  day: 15
PublicationDecade 2000
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
– name: New York
PublicationTitle Oncogene
PublicationTitleAlternate Oncogene
PublicationYear 2006
Publisher Nature Publishing
Nature Publishing Group
Publisher_xml – name: Nature Publishing
– name: Nature Publishing Group
References Rao, CV, Yang, M, Malisetty, S, Liu, T-Y, Fang, Y-Q, Mahmood, R 2005; 102
Wang, Q, Xie, S, Chen, J, Fukasawa, K, Naik, U, Traganos, F 2002; 22
Xie, S, Xie, B, Lee, MY, Dai, W 2005; 24
Cahill, DP, Lengauer, C, Yu, J, Riggins, GJ, Willson, JK, Markowitz, SD 1998; 392
Yang, Y, Li, CC, Weissman, AM 2004; 23
Chang, P, Jacobson, MK, Mitchison, TJ 2004; 432
Hanks, S, Coleman, K, Reid, S, Plaja, A, Firth, H, Fitzpatrick, D 2004; 36
Affar, EB, Germain, M, Winstall, E, Vodenicharov, M, Shah, RG, Salvesen, GS 2001; 276
Lew, DJ, Burke, DJ 2003; 37
Bashir, T, Dorrello, NV, Amador, V, Guardavaccaro, D, Pagano, M 2004; 428
Huber, A, Bai, P, de Murcia, JM, de Murcia, G 2004; 3
Hamid, T, Kakar, SS 2003; 18
Lengauer, C, Kinzler, KW, Vogelstein, B 1998; 396
Ouyang, B, Pan, H, Lu, L, Li, J, Stambrook, P, Li, B 1997; 272
Wieler, S, Gagne, JP, Vaziri, H, Poirier, GG, Benchimol, S 2003; 278
Nitta, M, Kobayashi, O, Honda, S, Hirota, T, Kuninaka, S, Marumoto, T 2004; 23
Smits, VA, Klompmaker, R, Arnaud, L, Rijksen, G, Nigg, EA, Medema, RH 2000; 2
Pirrotta, V 2004; 119
Bernal, JA, Luna, R, Espina, A, Lazaro, I, Ramos-Morales, F, Romero, F 2002; 32
Lengauer, C 2003; 300
Li, W, Lan, Z, Wu, H, Wu, S, Meadows, J, Chen, J 1999; 10
Saxena, A, Saffery, R, Wong, LH, Kalitsis, P, Choo, KH 2002; 277
Zhou, BB, Elledge, SJ 2000; 408
Redon, C, Pilch, D, Rogakou, E, Sedelnikova, O, Newrock, K, Bonner, W 2002; 12
Bloom, J, Amador, V, Bartolini, F, DeMartino, G, Pagano, M 2003; 115
Sancar, A, Lindsey-Boltz, LA, Unsal-Kacmaz, K, Linn, S 2004; 73
Bharadwaj, R, Yu, H 2004; 23
Mikhailov, A, Cole, RW, Rieder, CL 2002; 12
Zhou, Y, Mehta, KR, Choi, AP, Scolavino, S, Zhang, X 2003; 278
Menissier, dM, Ricoul, M, Tartier, L, Niedergang, C, Huber, A, Dantzer, F 2003; 22
Dai, W, Wang, Q, Liu, T-Y, Swamy, M, Fang, Y-Q, Xie, S-Q 2004; 15
BF1209392_CR25
BF1209392_CR24
BF1209392_CR23
BF1209392_CR22
BF1209392_CR29
BF1209392_CR28
BF1209392_CR27
BF1209392_CR26
BF1209392_CR21
BF1209392_CR20
BF1209392_CR19
BF1209392_CR14
BF1209392_CR13
BF1209392_CR12
BF1209392_CR11
BF1209392_CR18
BF1209392_CR17
BF1209392_CR16
BF1209392_CR15
BF1209392_CR10
BF1209392_CR31
BF1209392_CR9
BF1209392_CR30
BF1209392_CR8
BF1209392_CR7
BF1209392_CR6
BF1209392_CR5
BF1209392_CR4
BF1209392_CR3
BF1209392_CR2
BF1209392_CR1
References_xml – volume: 2
  start-page: 672
  year: 2000
  end-page: 676
  publication-title: Nat Cell Biol
  contributor:
    fullname: Medema, RH
– volume: 23
  start-page: 2016
  year: 2004
  end-page: 2027
  publication-title: Oncogene
  contributor:
    fullname: Yu, H
– volume: 12
  start-page: 1797
  year: 2002
  end-page: 1806
  publication-title: Curr Biol
  contributor:
    fullname: Rieder, CL
– volume: 10
  start-page: 769
  year: 1999
  end-page: 775
  publication-title: Cell Growth Differ
  contributor:
    fullname: Chen, J
– volume: 3
  start-page: 1103
  year: 2004
  end-page: 1108
  publication-title: DNA Repair (Amsterdam)
  contributor:
    fullname: de Murcia, G
– volume: 15
  start-page: 440
  year: 2004
  end-page: 445
  publication-title: Cancer Res
  contributor:
    fullname: Xie, S-Q
– volume: 18
  start-page: 245
  year: 2003
  end-page: 251
  publication-title: Histol Histopathol
  contributor:
    fullname: Kakar, SS
– volume: 428
  start-page: 190
  year: 2004
  end-page: 193
  publication-title: Nature
  contributor:
    fullname: Pagano, M
– volume: 392
  start-page: 300
  year: 1998
  end-page: 303
  publication-title: Nature
  contributor:
    fullname: Markowitz, SD
– volume: 22
  start-page: 2255
  year: 2003
  end-page: 2263
  publication-title: EMBO J
  contributor:
    fullname: Dantzer, F
– volume: 408
  start-page: 433
  year: 2000
  end-page: 439
  publication-title: Nature
  contributor:
    fullname: Elledge, SJ
– volume: 432
  start-page: 645
  year: 2004
  end-page: 649
  publication-title: Nature
  contributor:
    fullname: Mitchison, TJ
– volume: 272
  start-page: 28646
  year: 1997
  end-page: 28651
  publication-title: J Biol Chem
  contributor:
    fullname: Li, B
– volume: 37
  start-page: 251
  year: 2003
  end-page: 282
  publication-title: Annu Rev Genet
  contributor:
    fullname: Burke, DJ
– volume: 73
  start-page: 39
  year: 2004
  end-page: 85
  publication-title: Annu Rev Biochem
  contributor:
    fullname: Linn, S
– volume: 12
  start-page: 162
  year: 2002
  end-page: 169
  publication-title: Curr Opin Genet Dev
  contributor:
    fullname: Bonner, W
– volume: 24
  start-page: 277
  year: 2005
  end-page: 286
  publication-title: Oncogene
  contributor:
    fullname: Dai, W
– volume: 396
  start-page: 643
  year: 1998
  end-page: 649
  publication-title: Nature
  contributor:
    fullname: Vogelstein, B
– volume: 119
  start-page: 735
  year: 2004
  end-page: 736
  publication-title: Cell
  contributor:
    fullname: Pirrotta, V
– volume: 115
  start-page: 71
  year: 2003
  end-page: 82
  publication-title: Cell
  contributor:
    fullname: Pagano, M
– volume: 23
  start-page: 6548
  year: 2004
  end-page: 6558
  publication-title: Oncogene
  contributor:
    fullname: Marumoto, T
– volume: 278
  start-page: 18914
  year: 2003
  end-page: 18921
  publication-title: J Biol Chem
  contributor:
    fullname: Benchimol, S
– volume: 278
  start-page: 462
  year: 2003
  end-page: 470
  publication-title: J Biol Chem
  contributor:
    fullname: Zhang, X
– volume: 32
  start-page: 306
  year: 2002
  end-page: 311
  publication-title: Nat Genet
  contributor:
    fullname: Romero, F
– volume: 23
  start-page: 2096
  year: 2004
  end-page: 2106
  publication-title: Oncogene
  contributor:
    fullname: Weissman, AM
– volume: 22
  start-page: 3450
  year: 2002
  end-page: 3459
  publication-title: Mol Cell Biol
  contributor:
    fullname: Traganos, F
– volume: 36
  start-page: 1159
  year: 2004
  end-page: 1161
  publication-title: Nat Genet
  contributor:
    fullname: Fitzpatrick, D
– volume: 300
  start-page: 442
  year: 2003
  end-page: 443
  publication-title: Science
  contributor:
    fullname: Lengauer, C
– volume: 102
  start-page: 4365
  year: 2005
  end-page: 4370
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Mahmood, R
– volume: 277
  start-page: 26921
  year: 2002
  end-page: 26926
  publication-title: J Biol Chem
  contributor:
    fullname: Choo, KH
– volume: 276
  start-page: 2935
  year: 2001
  end-page: 2942
  publication-title: J Biol Chem
  contributor:
    fullname: Salvesen, GS
– ident: BF1209392_CR27
  doi: 10.1074/jbc.M211641200
– ident: BF1209392_CR4
  doi: 10.1038/sj.onc.1207374
– ident: BF1209392_CR22
  doi: 10.1016/S0959-437X(02)00282-4
– ident: BF1209392_CR25
  doi: 10.1038/35023629
– ident: BF1209392_CR16
  doi: 10.1093/emboj/cdg206
– ident: BF1209392_CR6
  doi: 10.1038/32688
– ident: BF1209392_CR3
  doi: 10.1038/ng997
– ident: BF1209392_CR7
  doi: 10.1038/nature03061
– ident: BF1209392_CR9
  doi: 10.1191/0267659103pf684oa
– ident: BF1209392_CR23
  doi: 10.1146/annurev.biochem.73.011303.073723
– ident: BF1209392_CR29
  doi: 10.1038/sj.onc.1207411
– ident: BF1209392_CR31
  doi: 10.1074/jbc.M203793200
– ident: BF1209392_CR28
  doi: 10.1038/sj.onc.1208218
– ident: BF1209392_CR21
  doi: 10.1073/pnas.0407822102
– ident: BF1209392_CR5
  doi: 10.1016/S0092-8674(03)00755-4
– ident: BF1209392_CR15
– ident: BF1209392_CR30
  doi: 10.1038/35044005
– ident: BF1209392_CR2
  doi: 10.1038/nature02330
– ident: BF1209392_CR19
  doi: 10.1074/jbc.272.45.28646
– ident: BF1209392_CR13
  doi: 10.1038/25292
– ident: BF1209392_CR18
  doi: 10.1038/sj.onc.1207873
– ident: BF1209392_CR1
  doi: 10.1074/jbc.M007269200
– ident: BF1209392_CR10
  doi: 10.1038/ng1449
– ident: BF1209392_CR12
  doi: 10.1126/science.1084468
– ident: BF1209392_CR26
  doi: 10.1128/MCB.22.10.3450-3459.2002
– ident: BF1209392_CR14
  doi: 10.1146/annurev.genet.37.042203.120656
– ident: BF1209392_CR24
  doi: 10.1074/jbc.M200620200
– ident: BF1209392_CR11
  doi: 10.1016/j.dnarep.2004.06.002
– ident: BF1209392_CR8
  doi: 10.1158/0008-5472.CAN-03-3119
– ident: BF1209392_CR20
  doi: 10.1016/j.cell.2004.12.002
– ident: BF1209392_CR17
  doi: 10.1016/S0960-9822(02)01226-5
SSID ssj0007902
Score 2.1728175
Snippet Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1...
Defective mitotic spindles or an impaired spindle–kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1...
Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-...
SourceID proquest
gale
crossref
pubmed
pascalfrancis
nature
SourceType Aggregation Database
Index Database
Publisher
StartPage 3598
SubjectTerms Animals
Antibiotics, Antineoplastic - toxicity
Biological and medical sciences
Blotting, Western
BUBR1 protein
Cell Cycle Proteins
Cell cycle, cell proliferation
Cell Line
Cell lines
Cell physiology
Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
Cyclin-dependent kinase inhibitor p21
Deoxyribonucleic acid
DNA
DNA damage
DNA Damage - physiology
DNA Repair - physiology
Doxorubicin
Doxorubicin - toxicity
Fibroblasts - drug effects
Flow Cytometry
Fluorescent Antibody Technique
Fundamental and applied biological sciences. Psychology
Gene expression
Genetics
Genomic instability
Genomics
HeLa Cells
Histone H2A
Histones - metabolism
Humans
Immunoprecipitation
Mass Spectrometry
Mass spectroscopy
Mice
Mitosis
Mitosis - drug effects
Mitosis - physiology
Molecular and cellular biology
Molecular Sequence Data
Oncology
p53 Protein
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose)
Poly(ADP-ribose) polymerase
Poly(ADP-ribose) Polymerases - metabolism
Protein Kinases - genetics
Protein Kinases - metabolism
Protein-Serine-Threonine Kinases
rho GTP-Binding Proteins - metabolism
Ribose
RNA Interference
RNA-mediated interference
Rodents
Signal Transduction - physiology
Spindles
Transfection
Tumor Suppressor Protein p53 - metabolism
Tumorigenesis
Tumors
Yeast
Title BubR1 is involved in regulation of DNA damage responses
URI http://dx.doi.org/10.1038/sj.onc.1209392
https://www.ncbi.nlm.nih.gov/pubmed/16449973
https://www.proquest.com/docview/227358081
https://www.proquest.com/docview/2641352520
https://search.proquest.com/docview/20738525
https://search.proquest.com/docview/21330176
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1da9tATKwp-4AxtqzdsnaZHwZ78urzfT-NNGspg4ZRVsibOZ_voIXZWZwM9u-ni88Jga0vxliydUiWTrrTSQAf84y7ilQ2zT0NR3JylipT0dTb0sugXH5TeP56Jq5u2bc5n8cFtzamVfY2cWOoq8aGNfIznLhJKN2ZZ18Wv9LQNSrsrsYWGgdwmGOkkA3g8Pxi9v1ma4tll3WIfkSWoiuT92UbqTpr7z83qILh7CjV-d60FI3ztrbm84VpkWO-a3Xxf190MyddvoQX0ZlMJp30X8EjVw_hcdde8s8Qnk77bm5DeHIdN9FfgzxflzckuWuTuxqN029X4U2y7JrSo5iSxidfZ5OkMj_R2CBgk0Xr2iO4vbz4Mb1KY_-E1HKhV2kliMmUZ856ww1lgpfairKUmhvlnWSGMIvPCaEoGgxEvNPEOYExmslKr-gxDOqmdm8h4UwYy5yWThlmaaUxisKPVJnPdGktG8Gnnn3FoiuTUWy2t6kq2vsCGV1ERiNm4G4R9Ge1NNbEYwBIJ1SiKiZE6eCUCT6C0z1MZJjdAx938tkR7CmM9-S1g0slKJP45kkvwCJqbFvk6Mfx0IYEyf4Duv37RvBhCw4jCjlqtWvWiJOFykA5fwCDULSnUozgTffb7IaGbqnWkr57mPgJPOuWgERK-CkMVsu1e49O0aocw4GcS7yqKRlHLfgLQBwJYA
link.rule.ids 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74073,74342,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJNMCSEoOyjbGx5QOLJLI6_4ifUjU0F1gpNm7Q3y3FsaZNIStMi8e85J06rSrC3KHfJWXe-8519vkPoQ5ZyV5LS4szTcCUnYzg3JcXeFl4G5fJt4fnJVIxv2bc7fhc33JqYVtnbxNZQl7UNe-SnsHCTULozSz_PfuHQNSqcrsYWGk_RdihVBcHX9tnF9Mf1yhbLLusQ_IgUgyuT9WUbaX7aPHyqQQXD3VGqso1lKRrnVW3NlzPTAMd81-ri_75ouyZdvkavojOZjDrpv0FPXDVAz7r2kn8GaOe87-Y2QM8n8RD9LZJny-KaJPdNcl-BcfrtSnhI5l1TehBTUvvky3SUlOYnGBsAtFm0rtlFt5cXN-djHPsnYMuFWuBSEJPmnjnrDTeUCV4oK4pCKm5y7yQzhFl4TwgF0UAg4p0izgmI0Uxa-Jzuoa2qrtwBSjgTxjKnpMsNs7RUEEXBT8rUp6qwlg3Rx559etaVydDt8TbNdfOggdE6MhowA3d10J_F3FgTrwEAnVCJSo9IroJTJvgQHW1gAsPsBnivk8-aYE_heENea7jMBWUSvjzsBaijxjY6Az-OhzYkQPYf0NXsG6KTFTiMKOSoVa5eAk4aKgNl_BEMQsGeSjFE-920WQ8N3FKlJH33OPETtDO-mVzpq6_T74foRbcdJDDhR2hrMV-69-AgLYrjqAV_AYwACqY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-2lHWDMbas3bJ2rR8Ge_JiWV_W00g_QvfRUMoKfTOyLEELs7M4Gey_38mWEwJb34xP9ok73ekkne4H8CFNuC1JaeLUUX8lJ2VxpksaO1M46Y3LtYXnL2fi4oZ9veW3If-pCWmVvU9sHXVZG79HPsaJm_jSnWkydiEt4ups-nn-K_YIUv6kNcBpPIYdyQRNBrBzcj67ul77ZdllIGJMkcQY1qR9CUeajZv7TzWao79HSlW6NUUFR72us_l8rhuUnutgL_4fl7bz0_QlvAiBZTTpRsIreGSrITzpoCb_DOHpaY_sNoTdy3Cg_hrkyaq4JtFdE91V6Kh-2xIfokUHUI8qi2oXnc0mUal_ouNBQptRa5s9uJme_zi9iAOWQmy4UMu4FEQnmWPWOM01ZYIXyoiikIrrzFnJNGEG3xNCUU24KHFWEWsFrtd0UriM7sOgqiv7FiLOhDbMKmkzzQwtFa6o8Cdl4hJVGMNG8LEXXz7vSmbk7VE3zfLmPkdB50HQ2NJLN_e2tFxoo8OVAOTjq1LlE5IpH6AJPoLDrZYoMLNF3u_0s2HYczja0teGLjNBmcQvD3oF5sF6mzzFmI57SBJk-w_qeiSO4HhN9j3y-WqVrVfYJvFVglL-QAtC0bdKMYI33bDZdA1DVKUkffcw82PYRQPIv3-ZfTuAZ93OkIgJP4TBcrGy7zFWWhZHwQj-Ajg3DtQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BubR1+is+involved+in+regulation+of+DNA+damage+responses&rft.jtitle=Oncogene&rft.au=Fang%2C+Y&rft.au=Liu%2C+T&rft.au=Wang%2C+X&rft.au=Yang%2C+Y-M&rft.date=2006-06-15&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=25&rft.issue=25&rft.spage=3598&rft_id=info:doi/10.1038%2Fsj.onc.1209392&rft.externalDocID=A189056265
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon